Trending Up0.0055 (2.9810%)
  • Bid / Lots
    0.1889/ 3
  • Ask / Lots
    0.2000/ 51
  • Open / Previous Close
    0.1875 / 0.1845
  • Day Range
    Low 0.1809
    High 0.2085
  • 52 Week Range
    Low 0.1500
    High 1.7800
  • Volume
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.1845
09:32 ET1130.1875
09:33 ET1000.1892
09:35 ET1000.1892
09:37 ET20000.1892
09:42 ET506000.193
09:44 ET16000.1911
09:48 ET1000.1911
09:50 ET3000.18695
10:00 ET10000.1855
10:04 ET1000.1899
10:13 ET5000.1812
10:18 ET12000.1811
10:29 ET502990.19
10:33 ET3000.1899
10:44 ET10000.1899
10:45 ET28490.19
10:49 ET46000.1895
10:51 ET6600.186
10:54 ET87860.1915
10:56 ET314780.1957
10:58 ET21000.1959
11:00 ET386220.1959
11:02 ET339000.1999
11:03 ET350000.2051
11:05 ET106000.188
11:07 ET323000.193
11:09 ET100300.19
11:12 ET3000.2079
11:14 ET130070.1994
11:16 ET40000.1995
11:18 ET11000.1998
11:20 ET9000.199899
11:21 ET11000.199899
11:23 ET38200.1924
11:25 ET2000.18995
11:27 ET23000.1875
11:39 ET1000.1923
11:56 ET5000.191
11:57 ET49380.188
12:12 ET1000.1917
12:21 ET3500.188001
12:28 ET12000.188
12:33 ET112120.1908
12:37 ET30000.189799
12:39 ET26000.1898
01:06 ET198860.1978
01:08 ET27340.2
01:13 ET8000.1999
01:15 ET10900.2
01:18 ET253390.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesWINT
Windtree Therapeutics Inc
United StatesADIL
Adial Pharmaceuticals Inc
United StatesXTLB
X T L Biopharmaceuticals Ltd
United StatesKTRA
Kintara Therapeutics Inc
United StatesNBSE
NeuBase Therapeutics Inc
United StatesTENX
Tenax Therapeutics Inc
As of 2022-11-29

Company Information

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of therapeutics intended to address significant unmet medical needs. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. Its Cardiovascular Program’s products candidates include Istaroxime, Oral SERCA2a Activators and Rostafuroxin. Its Pulmonary Program’s product candidates include Lyophilized KL4 Surfactant and AEROSURF (aerosolized KL4 surfactant based on ADS technology). The Company’s lead product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure (AHF) with a potentially differentiated safety profile from existing treatments. Istaroxime demonstrated significant improvement in both diastolic and systolic aspects of cardiac function and is under phase II clinical trials.

Contact Information

2600 Kelly Rd Ste 100WARRINGTON, PA, United States 18976-3652


Non-Executive Independent Chairman of the Board
James Huang
President, Chief Executive Officer, Director
Craig Fraser
Chief Financial Officer, Senior Vice President, Corporate Secretary
John Hamill
Chief Operating Officer, Senior Vice President
Eric Curtis
Senior Vice President, General Counsel
Diane Carman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.